Citation Impact
Citing Papers
An Overview of Autophagy: Morphology, Mechanism, and Regulation
2013 Standout
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Hedgehog signalling in cancer formation and maintenance
2003 Standout
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Potent thromboxane-mediated in vitro bronchoconstrictor effect of endothelin in the guinea-pig
1990
Degradation of excess peroxisomes in mammalian liver cells by autophagy and other mechanisms
2009
Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice
2013 Standout
Hedgehog: functions and mechanisms
2008 Standout
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
2003 StandoutNature
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
1998 StandoutNature
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
2006 Standout
PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
2003
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
2007 Standout
Loss of the Intermembrane Space Protein Mgm1/OPA1 Induces Swelling and Localized Constrictions along the Lengths of Mitochondria
2004
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
1992 StandoutNature
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
2002 StandoutScience
Vertebrate Smoothened functions at the primary cilium
2005 StandoutNature
Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose tolerance
1994
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
1990 StandoutNature
Mitochondria: More Than Just a Powerhouse
2006 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
The biology and pharmacology of PGD2
1988
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Defective Cholesterol Biosynthesis Associated with the Smith-Lemli-Opitz Syndrome
1994
The cornified envelope: a model of cell death in the skin
2005 Standout
Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology
2008
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
2000 StandoutNature
Mammalian peroxisomes and reactive oxygen species
2004
Alzheimer's disease
2006 Standout
Fish bioaccumulation and biomarkers in environmental risk assessment: a review
2002 Standout
Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly
1996 Standout
Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells
1992
Improved myocardial performance induced by dofibrate during reperfusion after acute myocardial infarction
1988
Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury
1990 Standout
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
1995 Standout
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Peroxisomes and oxidative stress
2006
Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome
2000
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
2001
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
2008 Standout
Serum metabolites of proanthocyanidin-administered rats decrease lipid synthesis in HepG2 cells
2013
Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened
2002 Standout
The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist
1989
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms.
1986
Effect of Thromboxane A 2 Blockade on Clinical Outcome and Restenosis After Successful Coronary Angioplasty
1995
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Teratogen-Mediated Inhibition of Target Tissue Response to Shh Signaling
1998 StandoutScience
Reactive Species and Antioxidants. Redox Biology Is a Fundamental Theme of Aerobic Life
2006 Standout
Products, kinetics, and substrate specificity of homogeneous thromboxane synthase from human platelets: Development of a novel enzyme assay
1987
Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans
1983
Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering
2001
Small molecule modulation of Smoothened activity
2002 Standout
Potent hypocholesterolemic activity of novel ureido phenoxyisobutyrates correlates with their intrinsic fibrate potency and not with their ACAT inhibitory activity
1997
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Defective forebrain development in mice lacking gp330/megalin.
1996 Standout
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Oxygen Radicals and Human Disease
1987 Standout
Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis
1994
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
1994 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Prostaglandins and Inflammation
2011 Standout
The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis
2001 Standout
Characterization of prostanoid relaxant/inhibitory receptors (ψ) using a highly selective agonist, TR4979
1986
Comparison of antioxidative capacities and inhibitory effects on cholesterol biosynthesis of quercetin and potential metabolites
2002
Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus
1992
Works of K. Stegmeier being referenced
New, rapid method for the separation of labelled sterols synthesized by cell cultures by means of Extrelut
1985
Atherosclerosis in the aorta of hypercholesterolemic rabbits and the influence of daltroban
1991
TRIGLYCERIDE LOWERING EFFECT AND INDUCTION OF LIVER ENZYMES IN MALE RATS AFTER ADMINISTRATION OF HYPOLIPIDEMIC DRUGS
1982
The effects of BM 15.766, an inhibitor of 7-dehydrocholesterol δ7-reductase∗, on cholesterol biosynthesis in primary rat hepatocytes
1986
Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
1984
STUDY OF LIVER ENZYMES: PEROXISOME PROLIFERATION AND TUMOR RATES IN RATS AT THE END OF CARCINOGENICITY STUDIES WITH BEZAFIBRATE AND CLOFIBRATE
1982
Investigations on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets
1984
Inhibition of Cholesterol Biosynthesis by BM 15.766
1985
Thin-layer chromatography of radioactively labelled cholesterol and precursors from biological material
1987
THE SHORT‐ AND LONG‐TERM EFFECTS OF BEZAFIBRATE IN THE RAT*
1982
Effects of BM 15.766 on Serum Lipids in Rats
1985
Effects of drugs affecting cholesterol biosynthesis pathway on BM 15.766-induced 7-dehydrocholesterol accumulation in rats. An animal model for testing compounds reducing cholesterol synthesis.
1990
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug
1984
The pharmacokinetic and pharmacodynamic profiles of the thromboxane A-2 receptor blocker BM 13.177
1986
Proliferation of peroxisomes in pericentral hepatocytes of rat liver after administration of a new hypocholesterolemic agent (BM 15766). Sex-dependent ultrastructural differences.
1987